Picture of IXICO logo

IXI IXICO News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

REG - IXICO plc - Grant of share options

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220110:nRSJ8069Xa&default-theme=true

RNS Number : 8069X  IXICO plc  10 January 2022

IXICO plc

("IXICO" or the "Company")

 

Grant of share options

 

IXICO plc (AIM: IXI), the data analytics company delivering insights in
neuroscience, announces that it has granted 300,000 options over the ordinary
shares in the Company in accordance with the rules of the Company's EMI Share
Option Plan 2014 (the 'Plan') exercisable at a share price of 1p.

 

These options are subject to performance conditions linked to compound share
price growth across three years.  Robin Wolz, Chief Scientific Officer,
Romina Oxborough, SVP Operations and Chris Hamilton, SVP Commercial who are
all considered PDMRs as members of the IXICO Senior Leadership Team, each
receive 100,000 options under this award.

 

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Robin Wolz

 2    Reason for the notification

 a)   Position/status                                              Chief Scientific Officer

 b)   Initial notification /Amendment                              Initial notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         IXICO plc

 b)   LEI                                                          2138005M1F59O6HWSA97

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary Shares in IXICO plc

      Identification code                                          GB00BCLY7L40

 b)   Nature of the transaction                                    Grant of share options

 c)   Price(s) and volume(s)

                                                                                     Price(s)          Volume(s)
                                                                                     1p                100,000

 d)   Aggregated information                                       N/A

      - Aggregated volume

      - Price

 e)   Date of the transaction                                      10 January 2022

 f)   Place of the transaction                                     Off market

 

 

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Romina Oxborough

 2    Reason for the notification

 a)   Position/status                                              PDMR (SVP Operations)

 b)   Initial notification /Amendment                              Initial notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         IXICO plc

 b)   LEI                                                          2138005M1F59O6HWSA97

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary Shares in IXICO plc

      Identification code                                          GB00BCLY7L40

 b)   Nature of the transaction                                    Grant of share options

 c)   Price(s) and volume(s)

                                                                                     Price(s)          Volume(s)
                                                                                     1p                100,000

 d)   Aggregated information

      - Aggregated volume                                          N/A

      - Price

 e)   Date of the transaction                                      10 January 2022

 f)   Place of the transaction                                     Off market

 

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                          Chris Hamilton

 2    Reason for the notification

 a)   Position/status                                              PDMR (SVP Commercial)

 b)   Initial notification /Amendment                              Initial notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         IXICO plc

 b)   LEI                                                          2138005M1F59O6HWSA97

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary Shares in IXICO plc

      Identification code                                          GB00BCLY7L40

 b)   Nature of the transaction                                    Grant of share options

 c)   Price(s) and volume(s)

                                                                                     Price(s)          Volume(s)
                                                                                     1p                100,000

 d)   Aggregated information                                       N/A

      - Aggregated volume

      - Price

 e)   Date of the transaction                                      10 January 2022

 f)   Place of the transaction                                     Off market

 

 

For further information please contact:

 

 IXICO plc                                                 +44 (0)20 3763 7498
 Giulio Cerroni, Chief Executive Officer

 Grant Nash, Chief Financial Officer

 Cenkos Securities PLC (Nominated adviser and sole broker)                  +44 (0)20 7397 8900
 Giles Balleny / Max Gould (Corporate Finance)
 Michael F Johnson / Russell Kerr (Sales)

 Walbrook PR Ltd     Tel: 020 7933 8780 or IXICO@walbrookpr.com

 Paul McManus / Lianne Applegarth /      Mob: 07980 541 893 / 07584 391 303 /
 Alice Woodings                          07407 804 654

 

About IXICO

IXICO is dedicated to delivering insights in neuroscience. Our purpose is to
advance medicine and human health by turning data into clinically meaningful
information, providing valuable new insights in neuroscience and our goal is
to be a leading proponent of artificial intelligence in medical image
analysis. We will achieve this by developing and deploying breakthrough data
analytics, at scale, through our remote access technology platform, to improve
the return on investment in drug development and reduce risk and uncertainty
in clinical trials for our pharmaceutical clients.

 

More information is available on www.IXICO.com (http://www.IXICO.com)  and
follow us on Twitter @IXICOnews

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHUBRURUOUARAR

Recent news on IXICO

See all news